<?xml version="1.0" encoding="UTF-8"?>
<ref id="B211-nutrients-13-00462">
 <label>211.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kastelein</surname>
    <given-names>J.J.P.</given-names>
   </name>
   <name>
    <surname>Maki</surname>
    <given-names>K.C.</given-names>
   </name>
   <name>
    <surname>Susekov</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ezhov</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Nordestgaard</surname>
    <given-names>B.G.</given-names>
   </name>
   <name>
    <surname>Machielse</surname>
    <given-names>B.N.</given-names>
   </name>
   <name>
    <surname>Kling</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Davidson</surname>
    <given-names>M.H.</given-names>
   </name>
  </person-group>
  <article-title>Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The Epanova for lowering very high triglycerides (EVOLVE) trial</article-title>
  <source>J. Clin. Lipidol.</source>
  <year>2014</year>
  <volume>8</volume>
  <fpage>94</fpage>
  <lpage>106</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jacl.2013.10.003</pub-id>
  <pub-id pub-id-type="pmid">24528690</pub-id>
 </element-citation>
</ref>
